Trials / Sponsors / Jubilant DraxImage Inc.
Jubilant DraxImage Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Neuroblastoma, Neuroectodermal Tumors, Neoplasms | Phase 2 | 2019-10-21 |
| Available | Expanded Access Protocol Using 131I-MIBG Neuroblastoma, Pheochromocytoma, Paraganglioma | — | — |